Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transarterial Drug-Eluting Chemoembolization for HCC Patients in Korea Using Transradial Approach

NCT07160374 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT07160374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07160374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transarterial Drug-Eluting Chemoembolization for HCC Patients in Korea Using Transradial Approach
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Completed
Start date
August 21, 2018
Completion date
August 4, 2025
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma